JJJaegyun Jung

Jaegyun Jung

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jaegyun Jung has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    FERMAT: An Autoregressive Clinical Foundation Model for Disease Risk and Clinical Event Prediction

    by Jaegyun Jung, Hyung-Chul Lee

    Clinical foundation models learn patterns in longitudinal health records that can be reused across prediction tasks. However, the relative strengths of representation-based and generation-based prediction across clinical tasks remain unclear. Using longitudinal electronic health records from 3.77 million patients at a single hospital, we developed FERMAT (Foundation model for Exploring Real-world Multimodal health data using Autoregressive Trajectory modeling), a 65-million-parameter clinical foundation model. We compared predictions from task-specific predictors trained on patient representations with those derived from generated clinical event sequences. Representation-based prediction performed better in the disease-risk comparisons. In detailed analyses of five-year chronic kidney disease, fatty liver, and diabetes risk in a test cohort of 10,000 patients, representation-based predictors exceeded generation-based estimates by 0.098–0.115 in observation-weighted AUROC and had lower probability error. Generation-based prediction, in turn, performed better in predicting diagnoses, prescriptions, and procedures recorded on the same day, a task motivated by the frequent presence of multiple events with the same date in hospital EHRs. Using 50 generated trajectories per patient, it achieved a Recall@10 of 71.0%, compared with 55.7% for representation-based prediction, with a paired improvement of 15.31 percentage points (95% CI, 13.92–16.79; n = 1,862). These findings demonstrate task-dependent strengths of representation-based and generation-based applications within a single clinical foundation model, providing an empirical basis for exploring how the two approaches can be used individually or combined to address clinical prediction needs.

  • Open Access

    Associations between physical activities and self-harm behaviour in depression across the genotype: findings from the UK biobank

    by Jaegyun Jung, Sangyeon Lee, Jeong Ho Lee, Doheon Lee

    Background: Physical activities are widely implemented for non-pharmacological intervention to alleviate depressive symptoms. However, there is little evidence supporting their genotype-specific effectiveness in reducing the risk of self-harm in patients with depression. Aims: To assess the associations between physical activity and self-harm behaviour and determine the recommended level of physical activity across the genotypes. Method: We developed the bidirectional analytical model to investigate the genotype-specific effectiveness on UK Biobank. After the genetic stratification of the depression phenotype cohort using hierarchical clustering, multivariable logistic regression models and Cox proportional hazards models were built to investigate the associations between physical activity and the risk of self-harm behaviour. Results: A total of 28 923 subjects with depression phenotypes were included in the study. In retrospective cohort analysis, the moderate and highly active groups were at lower risk of self-harm behaviour. In the followed prospective cohort analysis, light-intensity physical activity was associated with a lower risk of hospitalisations due to self-harm behaviour in one genetic cluster (adjusted hazard ratio, 0.28 [95% CI, 0.08–0.96]), which was distinguished by three genetic variants: rs1432639, rs4543289 and rs11209948. Compliance with the guideline-level moderate-to-vigorous physical activities was not significantly related to the risk of self-harm behaviour. Conclusions: A genotype-specific dose of light-intensity physical activity reduces the risk of self-harm by around a fourth in depressive patients.


  • Open Access

    Genotype-specific effects of physical activities on self-harm behavior in depressed patients: findings from the UK Biobank

    by Jaegyun Jung, Sangyeon Lee, Jeong Ho Lee, Doheon Lee

    Background Physical activities are widely implemented for non-pharmacological intervention in depression. However, there is little evidence supporting their genotype-specific effectiveness in reducing the risk of intentional self-harm in midlife and late-life depression patients. Aims To assess whether the specific type and amount of physical activity is associated with the risk of intentional self-harm behavior among patients with depression phenotype. Method We developed the bidirectional analytic model to investigate the genotype-specific effectiveness (BAIGE) on UK Biobank. After the genetic stratification on the depression phenotype cohort using hierarchical clustering, multivariable logistic regression models and Cox proportional hazard models were built to investigate the associations between physical activity and the risk of intentional self-harm behavior. Results A total of 28,923 subjects with depression phenotype were included in the study. In retrospective cohort analysis, the moderate and highly active groups were at lower risk of hospitalizations (moderate: adjusted odds ratio [OR], 0.77 [95% CI, 0.61-0.98], high: OR, 0.76 [95% CI, 0.60-0.97]). In the follow-up prospective cohort analysis, light-intensity physical activity (LIPA) was associated with a lower risk of hospitalizations in one genetic cluster (adjusted hazard ratio [HR], 0.26 [95% CI, 0.08 – 0.88]), which was distinguished by three genetic variants: rs1432639, rs4543289, and rs11209948. Compliance with the guideline-level moderate-to-vigorous physical activities was not significantly related to the risk of hospitalizations. Conclusions Physical activities, particularly a certain amount of light-intensity physical activity, mitigate the risk of hospitalizations due to self-harm in depression patients with a specific genotype.

  • Open Access

    Large-scale prediction of adverse drug reactions-related proteins with network embedding

    by Jaesub Park, Sangyeon Lee, Kwansoo Kim, Jaegyun Jung, Doheon Lee

    Adverse drug reactions (ADRs) are a major issue in drug development and clinical pharmacology. As most ADRs are caused by unintended activity at off-targets of drugs, the identification of drug targets responsible for ADRs becomes a key process for resolving ADRs. Recently, with the increase in the number of ADR-related data sources, several computational methodologies have been proposed to analyze ADR–protein relations. However, the identification of ADR-related proteins on a large scale with high reliability remains an important challenge. In this article, we suggest a computational approach, Large-scale ADR-related Proteins Identification with Network Embedding (LAPINE). LAPINE combines a novel concept called single-target compound with a network embedding technique to enable large-scale prediction of ADR-related proteins for any proteins in the protein–protein interaction network. Analysis of benchmark datasets confirms the need to expand the scope of potential ADR-related proteins to be analyzed, as well as LAPINE’s capability for high recovery of known ADR-related proteins. Moreover, LAPINE provides more reliable predictions for ADR-related proteins (Value-added positive predictive value = 0.12), compared to a previously proposed method (P < 0.001). Furthermore, two case studies show that most predictive proteins related to ADRs in LAPINE are supported by literature evidence. Overall, LAPINE can provide reliable insights into the relationship between ADRs and proteomes to understand the mechanism of ADRs leading to their prevention. The source code is available at GitHub (https://github.com/rupinas/LAPINE) and Figshare (https://figshare.com/articles/software/LAPINE/21750245) to facilitate its use. Supplementary data are available at Bioinformatics online.


  • Open Access

    Reliable Data Collection in Participatory Trials to Assess Digital Healthcare Applications

    by Junseok Park, Seongkuk Park, Gwangmin Kim, Kwangmin Kim, Jaegyun Jung, Sunyong Yoo, Gwan-Su Yi, Doheon Lee

    The number of digital healthcare mobile applications in the market is exponentially increasing owing to the development of mobile networks and widespread usage of smartphones. However, only few of these applications have been adequately validated. Like many mobile applications, in general, the use of healthcare applications is considered safe; thus, developers and end users can easily exchange them in the marketplace. However, existing platforms are unsuitable for collecting reliable data for evaluating the effectiveness of the applications. Moreover, these platforms reflect only the perspectives of developers and experts, and not of end users. For instance, typical clinical trial data collection methods are not appropriate for participant-driven assessment of healthcare applications because of their complexity and high cost. Thus, we identified the need for a participant-driven data collection platform for end users that is interpretable, systematic, and sustainable, as a first step to validate the effectiveness of the applications. To collect reliable data in the participatory trial format, we defined distinct stages for data preparation, storage, and sharing. The interpretable data preparation consists of a protocol database system and semantic feature retrieval method that allow a person without professional knowledge to create a protocol. The systematic data storage stage includes calculation of the collected data reliability weight. For sustainable data collection, we integrated a weight method and a future reward distribution function. We validated the methods through statistical tests involving 718 human participants. The results of a validation experiment demonstrate that the compared methods differ significantly and prove that the choice of an appropriate method is essential for reliable data collection, to facilitate effectiveness validation of digital healthcare applications. Furthermore, we created a Web-based system for our pilot platform to collect reliable data in an integrated pipeline. We compared the platform features using existing clinical and pragmatic trial data collection platforms.


  • Open Access

    Reliable data collection in participatory trials to assess digital healthcare apps

    by Junseok Park, Seongkuk Park, Kwangmin Kim, Gwangmin Kim, Jaegyun Jung, Sungyong Yoo, Gwan-Su Yi, Doheon Lee

    The number of digital healthcare mobile apps on the market is increasing exponentially owing to the development of the mobile network and widespread usage of smartphones. However, only a few of these apps have undergone adequate validation. As with many mobile apps, healthcare apps are generally considered safe to use, making them easy for developers and end-users to exchange them in the marketplace. The existing platforms are not suitable to collect reliable data for evaluating the effectiveness of the apps. Moreover, these platforms only reflect the perspectives of developers and experts, not of end-users. For instance, data collection methods typical of clinical trials are not appropriate for participant-driven assessment of healthcare apps because of their complexity and high cost. Thus, we identified a need for a participant-driven data collection platform for end-users that is interpretable, systematic, and sustainable —as a first step to validate the effectiveness of the apps. To collect reliable data in the participatory trial format, we defined distinct stages for data preparation, storage, and sharing. Interpretable data preparation consists of a protocol database system and semantic feature retrieval method to create a protocol without professional knowledge. Collected data reliability weight calculation belongs to the systematic data storage stage. For sustainable data collection, we integrated the weight method and the future reward distribution function. We validated the methods through statistical tests conducted on 718 human participants. The validation results demonstrate that the methods have significant differences in the comparative experiment and prove that the choice of the right method is essential for reliable data collection. Furthermore, we created a web-based system for our pilot platform to collect reliable data in an integrated pipeline. We validate the platform features with existing clinical and pragmatic trial data collection platforms. In conclusion, we show that the method and platform support reliable data collection, forging a path to effectiveness validation of digital healthcare apps.

  • Open Access

    Multidimensional Aspects of de qi Sensations in MASS and ASQ Assessment: A Pilot Study

    by Jong-Chan Jang, Jaegyun Jung, Haebeom Lee, Young-Bae Park, Hyunho Kim

    Background. De qi comprises varied senses depending on the individual. No single method can yet fully measure the multiple dimensions of de qi adequately. Objective. We examined the advantages of implementing multiple questionnaires for de qi measurement. Methods. Fourteen participants completed a preacupuncture questionnaire regarding their perception toward acupuncture treatment. After acupuncture stimulation at the HT7 point, de qi sensations were measured by MASS and ASQ. In groups with different levels of expectation, we compared the subtotal scores of each phase in the ASQ, as well as the VAS de qi intensity and MASS index using Kruskal‐Wallis test. For the structural comparison of questionnaires, we first performed Spearman’s rank correlation test between the scores of individual descriptors in MASS and ASQ. The subtotal scores of each phase in ASQ was compared with VAS de qi intensity and MASS index. Results. The subtotal score of the manipulation phase in ASQ strongly correlated with the VAS score of de qi intensity (Spearman’s ρ = 0.654, p = 0.011) and MASS index (Spearman’s ρ = 0.488, p = 0.076). MASS and ASQ showed strong correlations in certain analogous descriptors. Unpleasant perceptions toward acupuncture treatment did not significantly correlate with overall de qi intensity. Conclusions. De qi sensations in acupuncture treatment have multidimensional aspects. Intensity of stimulation, ASQ, and MASS index assess somewhat restricted aspects of de qi. Those questionnaires have exclusive differences of sets in spite of their strong intersections. Use of multiple questionnaires may enable a more comprehensive understanding of de qi properties and the elicitation of relevant construction in de qi features of acupuncture.